The Medicines Patent Pool (MPP) will participate in AFRAVIH 2026, taking place in Lausanne, Switzerland, bringing together francophone stakeholders engaged in the fight against HIV and other viral infections.

AFRAVIH convenes clinicians, researchers, community representatives, policymakers and international partners to share knowledge, strengthen collaboration and advance equitable access to prevention, treatment and care across francophone countries. The conference provides an important platform to address persistent gaps in access and to promote innovation in global health.

MPP colleagues will actively participate in the following sessions:

MPP-Unitaid Satellite Symposium – See HERE on the AFRAVIH website

Expanding choice, expanding impact: Increasing access to WHO-recommended HIV treatment options beyond TLD
Monday, 4 May 2026 | 14:30–15:30 | Room 3 – Moritz B

This session will explore the growing range of alternative HIV treatment options recommended by WHO, including TAF-based regimens, oral dual therapies and long-acting injectables. While TLD remains the backbone of HIV treatment globally, it is not suitable for all populations. Expanding access to alternative options is essential to better address diverse clinical needs and patient preferences.

The session will examine the current landscape of these therapies, barriers to their adoption and scale-up, and opportunities to accelerate equitable access in francophone low- and middle-income countries. Perspectives from communities, clinicians, national programmes and global health partners will highlight actionable solutions to translate innovation into real-world impact.

  • Welcome remarks – Anne-Claire Amprou (French Ambassador for Global Health & Chair of the Board, Unitaid)
  • Access to non-TLD treatments: where do we stand? – Sébastien Morin (Senior Manager – Policy, Strategy and Market Access, MPP, Switzerland)
  • Panel discussion (moderated by Gelise McCullough, Communications Director, MPP, Switzerland):
    • Community perspective – Ibrahima Ba (Bokk Yakaar, Senegal)
    • Clinical and normative perspective – Alexandra Calmy (Head of the HIV/AIDS Unit at HUG and member of the WHO Guidelines Development Group, Switzerland)
    • Country perspective – Dr Aniss Lakhel (Ministry of Health and Social Protection, Morocco)
    • Perspective of the UNAIDS Regional Office for West, Central, and North Africa – Ange-Valérie Meralli-Ballou (Regional Advisor for Public Health and HIV, UNAIDS Regional Office, Dakar, Senegal)
    • Country perspective – Prof. Charles Kouanfack (Faculty of Medicine and Pharmaceutical Sciences, University of Dschang, Cameroon)
  • Closing remarks – Philippe Duneton (Unitaid, Switzerland)
  • Master of ceremony – Marie Levy (Policy and Advocacy Officer, MPP, Switzerland)

AFRAVIH Plenary Session 2
Wednesday, 6 May 2026 | From 08:30 | Room 1 – Théâtre

  • 09:30: Long-acting PrEP: challenges and access enablers – Lobna Gaayeb (Head of Scientific and Medical Affairs, MPP, Switzerland)

See the program of the plenary here

Meet us at the Booth 6!

Through its engagement at AFRAVIH 2026, MPP aims to support a more diversified, people-centered HIV response and contribute to accelerating access to innovative health technologies where they are most needed.